Golden
Cognition Therapeutics

Cognition Therapeutics

Cognition Therapeutics is a biotechnology and pharmaceutical company developing therapeutics for Alzheimer’s disease and other neurodegenerative disorders that is headquartered in Pittsburgh, Pennsylvania in 2007 by Gilbert Rishton and Susan Catalano.

Cognition Therapeutics is a biotechnology and pharmaceutical company that was founded by Gilbert Rishton and Susan Catalano in 2007, and is headquartered in Pittsburgh, Pennsylvania. Cognition Therapeutics engages in drug development and discovery to develop novel approaches to the treatment of central nervous system disorders. The companies treatment approach to central nervous system disorders, such as Alzheimers disease and other neurodegenerative disorders, is to prevent the accumulation of toxic proteins associated with central nervous system disorders through the discovery and application of small molecule drug therapies. 

Timeline

People

Name
Role
Related Golden topics

Alexander Craig

Investor



Alicia Syrett

Investor



Anne Estabrook

Investor



David Hunt/Hunt Technology Ventures, L.P.

Investor



Deb Gerardi Kemper

Investor



Elinor MacKinnon

Investor



Gilbert Rishton

Chief Medicinal Chemistry Advisor



Hank Safferstein

Senior Vice President



Hans Hugh Miller

Investor



Jacqueline Dedell

Investor



Jean Peters

Investor



Jenevra Georgini

Investor



John B Goodrich

Investor



Kat Dave

Investor



Kenneth Moch

President & CEO



Marc Brands

Investor



Marcia Rick Dawood

Investor



Marjorie Kaufman, CFA

Investor



Michael Grundman

Chief Medical Advisor



Robert Windsor

Investor



Squirrel Hill Ventures

Investor



Stephen DiPalma

Chief Financial Officer



Susan Catalano

Founder & Chief Science Officer



Further reading

Title
Author
Link
Type







Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References